Entering text into the input field will update the search result below

Ventana and MedImmune collaborate

Jun. 04, 2014 11:29 AM ETRoche Holding AG (RHHBY) StockRHHBY, AZNBy: Douglas W. House, SA News Editor
  • Roche's (OTCQX:RHHBY -0.2%) Ventana Medical Systems and AstraZeneca's (AZN) MedImmune will jointly develop a PD-L1 immunohistochemistry assay to screen patients for MedImmune's clinical trials for MEDI4736, an anti-PDL1 therapy for non-small cell lung cancer. Financial terms are not disclosed.

Recommended For You

More Trending News

About RHHBY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RHHBY--
Roche Holding AG